The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
R47H TREM2 variant increases risk of typical early‐onset Alzheimer's disease but not of prion or frontotemporal dementia
Open accessAbstract
Background: Rare TREM2 variants are significant risk factors for Alzheimer's disease (AD). Methods: We used next generation sequencing of the whole gene (n = 700), exon 2 Sanger sequencing (n = 2634), p.R47H genotyping (n = 3518), and genome wide association study imputation (n = 13,048) to determine whether TREM2 variants are risk factors or phenotypic modifiers in patients with AD (n = 1002), frontotemporal dementia (n = 358), sporadic (n = 2500), and variant (n = 115) Creutzfeldt‐Jakob disease (CJD). Results: We confirm only p.R47H as a risk factor for AD (odds ratio or OR = 2.19; 95% confidence interval or CI = 1.04‐4.51; P = .03). p.R47H does not significantly alter risk for frontotemporal dementia (OR = 0.81), variant or sporadic CJD (OR = 1.06 95%CI = 0.66‐1.69) in our cohorts. Individuals with p.R47H associated AD (n = 12) had significantly earlier symptom onset than individuals with no TREM2 variants (n = 551) (55.2 years vs. 61.7 years, P = .02). We note that heterozygous p.R47H AD is memory led and otherwise indistinguishable from “typical” sporadic AD. Conclusion: We find p.R47H is a risk factor for AD, but not frontotemporal dementia or prion disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“R47H is clearly linked to an increased risk of AD [40, 41]”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Wechsler Abbreviated Scale of Intelligence
Dumont, R., Willis, J. O., Veizel, K., & Zibulsky, J. (2014) · Wiley eBooks · doi:10.1002/9781118660584.ese2519 · Cited by 5,546
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citationVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329
Self-citationPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683
Research works printed but not linked: 4
- Benitez B.A., 2013, TREM2 and neurodegenerative disease, N Engl J Med, 369, 1567
- Warrington E.K., 1984, Manual for the recognition memory test for words and faces
- Warrington E., 1991, The visual object and space perception battery
- Rajagopalan P., 2013, TREM2 and neurodegenerative disease, N Engl J Med, 369, 1565
Cited by
Sorted by citations
Items 101–120 of 120
Familial cerebral amyloid disorders with prominent white matter involvement
Banerjee, G., Schott, J. M., & Ryan, N. S. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00010-7 · Cited by 3
Self-citationAn Update on Neuroaging on Earth and in Spaceflight
Kuznetsov, N. V., Statsenko, Y. A., & Ljubisavljević, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041738 · Cited by 6
Suche nach Risikogenen bei der Alzheimer-Erkrankung
Karaca, I., Wagner, H., & Ramı́rez, A. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0354-7 · Cited by 3
Snyder, P. J. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.01.001 · Cited by 3
Innate immune crosstalk in ALS/FTD pathogenesis
Shu, X., Yu, X., Xu, P., & Wang, A. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100340 · Cited by 2
Genetics and Epigenetics in the Neurodegenerative Disorders of the Central Nervous System
Fenoglio, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_1 · Cited by 2
Biomarkers for Neurodegenerative Diseases
Abdelmoaty, M. M., Lu, E., & Foster, E. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_44 · Cited by 2
Xi, J., Yang, X., Zhao, Q., Zheng, J., An, R., Tian, S., Huang, H., Hu, F., Ning, P., & Xu, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.029 · Cited by 2
Reddy, J. S., Wang, X., Allen, M., Carrasquillo, M. M., Biernacka, J. M., Jenkins, G. D., Coombes, B. J., Belbin, O., Golde, T. E., Ertekin‐Taner, N., et al. (2022) · medRxiv · doi:10.1101/2022.07.12.22277557 · Cited by 2
Liu, Q., Lin, R., Gao, P.-R., Chen, D.-F., & Li, H. (2026) · Journal of International Medical Research · doi:10.1177/03000605261456056 · Cited by 1
Reddy, J. S., Wang, X., Allen, M., Carrasquillo, M. M., Biernacka, J. M., Jenkins, G. D., Coombes, B. J., Belbin, O., Golde, T. E., Ertekin‐Taner, N., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1885551/v1 · Cited by 1
Statistical Analyses to Detect and Refine Genetic Associations with Neurodegenerative Diseases
Katsumata, Y. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.486
Hurst, M. (2009) · RePEc: Research Papers in Economics
Emerging Roles of TREM2 in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_7
TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive DeclinePreprint
Dijkstra, J. I. R., Vermunt, L., Venkatraghavan, V., Ozhegov, G., Coomans, E. M., Ossenkoppele, R., van de Giessen, E., Hulsman, M., de Geus, C. M., van der Flier, W. M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5310076/v1
HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease
Esandi, J., Renault, P., Capilla-López, M. D., Blanch, R., Edo, Á., Ramirez-Gómez, D., Bosch, A., Almolda, B., Saura, C. A., Giraldo, J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117815
Cousins, O., Schubert, J. J., Chandra, A., Veronese, M., Valkimadi, P., Creese, B., Khan, Z., Arathimos, R., Hampshire, A., Rosenzweig, I., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24603603
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Chu, M., Tan, M., Gan, X., Cui, S., & Shi, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06091-5
Metadata
- Authors
- Slattery, C. F., Beck, J. A., Harper, L., Adamson, G., Abdi, Z., Uphill, J., Campbell, T., Druyeh, R., Mahoney, C. J., Rohrer, J. D., Kenny, J., Lowe, J., Leung, K. K., Barnes, J., Clegg, S. L., Blair, M., Nicholas, J. M., Guerreiro, R. J., Rowe, J. B., Ponto, C., Zerr, I., Kretzschmar, H., Gambetti, P., Crutch, S. J., Warren, J. D., Rossor, M. N., Fox, N. C., Collinge, J., Schott, J. M., & Mead, S.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- Department of Neurodegenerative Disease MRC Prion Unit, UCL Institute of Neurology London UK
- MRC Prion Unit (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Cambridge (GB)
- University of Göttingen (DE)
- Institut für Neuropathologie (DE)
- Case Western Reserve University (US)
- Corresponding author
- Mead, Simon
- ORCID
- Abdi, Zeinab
- Campbell, Tracy
- Mahoney, Colin J.
- Rohrer, Jonathan D.
- Kenny, Janna
- Lowe, Jessica
- Barnes, Josephine
- Clegg, Shona L.
- Blair, Melanie
- Nicholas, Jennifer M.
- Guerreiro, Rita J.
- Rowe, James B.
- Zerr, Inga
- Gambetti, Pierluigi
- Crutch, Sebastian J.
- Warren, Jason D.
- Rossor, Martin N.
- Fox, Nick C.
- Collinge, John
- Schott, Jonathan M.
- Mead, Simon
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2014-08-23
- Volume
- 10
- Issue
- 6
- Pages
- 602
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC4627504
- OpenAlex
- W1973742293
- Cited by
- 119
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 8 · 2022: 14 · 2021: 12 · 2020: 7 · 2019: 14 · 2018: 11 · 2017: 13 · 2016: 7 · 2015: 10
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Medical Research Council
- Alzheimer's Research
- NIHR Queen Square Dementia Biomedical Research Unit
- Leonard Wolfson Experimental Neurology Centre
- University College London Hospitals NHS Trust Biomedical Research Centre
- MRC (G0000934)
- Wellcome Trust (068545/Z/02, 088324)
- Brain Research Trust
- Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- TREM2
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Arginine, Brain, Exons, Female, Genotype, Histidine, Humans, Creutzfeldt-Jakob Syndrome, Male, Membrane Glycoproteins, Middle Aged, Phenotype, Receptors, Immunologic, Risk Factors, Genetic Variation, Cohort Studies, Genetic Predisposition to Disease, Genome-Wide Association Study, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
